RaNA Therapeutics Receives $20,700,000 Series A Funding
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a8e68987-f9a2-4191-8a3c-45137754fe5c&Preview=1
Date 1/18/2012
Company Name RaNA Therapeutics
Mailing Address 25 First Street Cambridge, MA 02141
Company Description RaNA was initially named IncRNA Inc., possibly a reference to intergenic non-coding RNA, the RNA that doesn’t make proteins but still performs a cellular function.
Proceeds Purposes The Series A funds will be used to accelerate R&D efforts across a range of disease areas, expand RaNA’s broad IP estate in the field of long non-coding RNA, and expand the core team.